The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: Results of a prospective study with mature survival data

Radiotherapy and Oncology

Volumn 106, Issue 3, 2013, Pages 292-298

  Mac Manus, Michael P ^a,b   Everitt, Sarah ^a   Bayne, Mike ^c   Ball, David ^a,b   Plumridge, Nikki ^a,b   Binns, David ^a   Herschtal, Alan ^a   Cruickshank, Deborah ^a   Bressel, Mathias ^a   Hicks, Rodney J ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Chemotherapy; Non small cell lung cancer; Positron emission tomography; Radiotherapy; Survival

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PALLIATIVE THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TUMOR BURDEN;

EID: 84876114211     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.12.018     Document Type: Article

References (31)

1. D. De Ruysscher, U. Nestle, R. Jeraj, and M. Macmanus PET scans in radiotherapy planning of lung cancer Lung Cancer 75 2012 141 145
2. J. van Loon, A. van Baardwijk, and L. Boersma Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancer Cancer Treat Rev 37 2011 331 343
3. R.L. Wahl, J.M. Herman, and E. Ford The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy Semin Radiat Oncol 21 2011 88 100
4. M. MacManus, U. Nestle, and K.E. Rosenzweig Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
5. P. Lin, E.S. Koh, and M. Lin Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer Radiother Oncol 101 2011 284 290
6. D. De Ruysscher, and C.M. Kirsch PET scans in radiotherapy planning of lung cancer Radiother Oncol 96 2010 335 338
7. M.P. Mac Manus Use of PET/CT for staging and radiation therapy planning in patients with non-small cell lung cancer Q J Nucl Med Mol Imaging 54 2010 510 520
8. J. Bradley, K. Bae, and N. Choi A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515 Int J Radiat Oncol Biol Phys 82 2012 e431
9. M.P. Mac Manus, R.J. Hicks, and D.L. Ball F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment Cancer 92 2001 886 895
10. T. Leong, C. Everitt, and K. Yuen A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer Radiother Oncol 78 2006 254 261
11. P. Bowden, R. Fisher, and M. Mac Manus Measurement of lung tumor volumes using three-dimensional computer planning software Int J Radiat Oncol Biol Phys 53 2002 566 573
12. M. Bayne, R.J. Hicks, and S. Everitt Reproducibility of "intelligent" contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method Int J Radiat Oncol Biol Phys 77 2010 1151 1157
13. S. Everitt, T. Kron, and N. Fimmell Interplanner variability in carrying out three-dimensional conformal radiation therapy for non-small-cell lung cancer J Med Imaging Radiat Oncol 52 2008 293 296
14. 18F] fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study Int J Radiat Oncol Biol Phys 80 2011 1008 1014
15. M.P. Mac Manus, M. Wada, J.P. Matthews, and D.L. Ball Characteristics of 49 patients who survived for 5 years following radical radiation therapy for non-small cell lung cancer: the potential for cure Int J Radiat Oncol Biol Phys 46 2000 63 69
16. D. Ball, J. Bishop, and J. Smith A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial Radiother Oncol 52 1999 129 136
17. L. Wang, C.R. Correa, and L. Zhao The effect of radiation dose and chemotherapy on overall survival in 237 patients with stage III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 73 2009 1383 1390
18. F. Siddiqui, K. Bae, and C.J. Langer The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trials J Thorac Oncol 5 2010 631 639
19. A.R. Feinstein, D.M. Sosin, and C.K. Wells The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer N Engl J Med 312 1985 1604 1608
20. A.B. Chen, B.A. Neville, and D.J. Sher Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulation J Clin Oncol 29 2011 2305 2311
21. L.J. Peters, B. O'Sullivan, and J. Giralt Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02 J Clin Oncol 28 2010 2996 3001
22. M.K. Gould, W.G. Kuschner, and C.E. Rydzak Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis Ann Intern Med 139 2003 879 892
23. M.K. Gould, C.C. Maclean, and W.G. Kuschner Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis JAMA 285 2001 914 924
24. 18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives Radiother Oncol 81 2006 209 225
25. M.P. Macmanus, and R.J. Hicks Where do we draw the line? Contouring tumors on positron emission tomography/computed tomography Int J Radiat Oncol Biol Phys 71 2008 2 4
26. A. Schaefer, U. Nestle, and S. Kremp Multi-centre calibration of an adaptive thresholding method for PET-based delineation of tumour volumes in radiotherapy planning of lung cancer Nuklearmedizin 51 2012 101 110
27. W. van Elmpt, D. De Ruysscher, and A. van der Salm The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer Radiother Oncol 104 2012 67 71
28. M. Massaccesi, M.L. Calcagni, and M.G. Spitilli (1)(8)F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose Radiat Oncol 7 2012 106
29. E.J. Somer, L.C. Pike, and P.K. Marsden Recommendations for the use of positron emission tomography and positron emission tomography-CT for radiotherapy planning in research projects Br J Radiol 2012
30. S. Everitt, A. Herschtal, and J. Callahan High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer Cancer 116 2010 5030 5037
31. M.P. Mac Manus, and R.J. Hicks How can we tell if PET imaging for cancer is cost effective? Lancet Oncol 11 2010 711 712